4D-110 for choroideremia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Jun 2020: Trial started, NCT04483440
  2. 23 Jul 2020: Trial registered, NCT04483440

The trials

NCT04483440: Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

State
Under way
Phase
Phase 1
People
13 taking part
Started
2 Jun 2020
Primary completion
26 May 2027
Arms
4D-110 Dose 1, 4D-110 Dose 2, 4D-110 Dose 3
Results
None posted
  1. 2 Jun 2020: Trial started
  2. 23 Jul 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.